BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 685-690

  Yi, Eun Hee ^a   Yoo, Hyouna ^b   Noh, Kum Hee ^a   Han, Songhee ^a   Lee, Haeri ^a   Lee, Jin Ku ^a   Won, Cheolhee ^a   Kim, Byung Hak ^a   Kim, Myoung Hwan ^a,c   Cho, Chung Hyun ^a   Ye, Sang kyu ^a  

^a Seoul National University   (South Korea)

^b Isu Abxis Co Ltd   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

BST 2; Metastasis; STAT3; Tamoxifen resistance

Indexed keywords

BONE MARROW STROMAL CELL ANTIGEN 2; MATRIGEL; MEMBRANE PROTEIN; STAT3 PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTATIC MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WOUND HEALING;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DRUG INTERACTIONS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM INVASIVENESS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 84878969094     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.043     Document Type: Article

References (19)

1. Min Y.S., Yi E.H., Lee J.K., Choi J.W., Sim J.H., Kang J.S., Kim Y.N., Juhnn Y.S., Kim H.R., Ye S.K. CK20 expression enhances the invasiveness of tamoxifen-resistant MCF-7 cells. Anticancer Res. 2012, 32:1221-1228.
2. Ishikawa J., Kaisho T., Tomizawa H., Lee B.O., Kobune Y., Inazawa J., Oritani K., Itoh M., Ochi T., Ishihara K., et al. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 1995, 26:527-534.
3. Yoo H., Park S.H., Ye S.K., Kim M. IFN-gamma-induced BST2 mediates monocyte adhesion to human endothelial cells. Cell. Immunol. 2011, 267:23-29.
4. Wainwright D.A., Balyasnikova I.V., Han Y., Lesniak M.S. The expression of BST2 in human and experimental mouse brain tumors. Exp. Mol. Pathol. 2011, 91:440-446.
5. Becker M., Sommer A., Kratzschmar J.R., Seidel H., Pohlenz H.D., Fichtner I. Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM. Mol. Cancer Ther. 2005, 4:151-168.
6. Kawai S., Azuma Y., Fujii E., Furugaki K., Ozaki S., Matsumoto T., Kosaka M., Yamada-Okabe H. Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci. 2008, 99:2461-2466.
7. Cai D., Cao J., Li Z., Zheng X., Yao Y., Li W., Yuan Z. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC Cancer 2009, 9:102.
8. Yi E.H., Lee C.S., Lee J.K., Lee Y.J., Shin M.K., Cho C.H., Kang K.W., Lee J.W., Han W., Noh D.Y., Kim Y.N., Cho I.H., Ye S.K. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells. Mol. Cancer Res. 2013, 11:31-42.
9. Qian H., Yu J., Li Y., Wang H., Song C., Zhang X., Liang X., Fu M., Lin C. RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol. Cell 2007, 99:573-581.
10. Hofmann U.B., Eggert A.A., Blass K., Brocker E.B., Becker J.C. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res. 2003, 63:8221-8225.
11. Beviglia L., Stewart G.J., Niewiarowski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol. Res. 1995, 7:7-20.
12. Hiscox S., Jiang W.G., Obermeier K., Taylor K., Morgan L., Burmi R., Barrow D., Nicholson R.I. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int. J. Cancer 2006, 118:290-301.
13. Acharyya S., Oskarsson T., Vanharanta S., Malladi S., Kim J., Morris P.G., Manova-Todorova K., Leversha M., Hogg N., Seshan V.E., Norton L., Brogi E., Massague J. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012, 150:165-178.
14. Kim M., Koh Y.J., Kim K.E., Koh B.I., Nam D.H., Alitalo K., Kim I., Koh G.Y. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 2010, 70:10411-10421.
15. Rew S.B., Peggs K., Sanjuan I., Pizzey A.R., Koishihara Y., Kawai S., Kosaka M., Ozaki S., Chain B., Yong K.L. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24. Clin. Cancer Res. 2005, 11:3377-3384.
16. Real P.J., Sierra A., De Juan A., Segovia J.C., Lopez-Vega J.M., Fernandez-Luna J.L. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 2002, 21:7611-7618.
17. Wei D., Le X., Zheng L., Wang L., Frey J.A., Gao A.C., Peng Z., Huang S., Xiong H.Q., Abbruzzese J.L., Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003, 22:319-329.
18. Xie T.X., Huang F.J., Aldape K.D., Kang S.H., Liu M., Gershenwald J.E., Xie K., Sawaya R., Huang S. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 2006, 66:3188-3196.
19. Guzzo C., Jung M., Graveline A., Banfield B.W., Gee K. IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. Sci. Rep. 2012, 2:974.